ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANVS vs ATNM // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Annovis Bio Inc. (NYSE) VS. Actinium Pharmaceuticals Inc. (Delaware) (NYSE) • 15-METRIC TALLY: ANVS 1 — ATNM 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANVS VS. ATNM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANVS ATNM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 ATNM /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.0 56.3 -8.30 ATNM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $46.1M $45.0M $1.1M ANVS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANVS REV ATNM REV ANVS GROSS % ATNM GROSS % ANVS FCF ATNM FCF
FY 2025 $83.1M $90.0K — — -$25.6M -$24.7M
FY 2024 $74.7M $117.9M — — -$21.9M -$33.1M
FY 2023 $126.1M $81.0K — — -$40.0M -$47.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANVS // BETA —
ATNM // BETA —